Clinical ResearchPro–Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides
-
Add time:08/30/2019 Source:sciencedirect.com
ObjectivesThe aim of this study was to determine if the atrial natriuretic peptide (ANP) precursor proANP is biologically active compared with ANP and B-type natriuretic peptide (BNP).
We also recommend Trading Suppliers and Manufacturers of atrial natriuretic factor (7-23), Pro(10)- (cas 114284-25-2). Pls Click Website Link as below: cas 114284-25-2 suppliers
Prev:Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients
Next:Mini-Focus Issue: Natriuretic PeptideEffect of Neprilysin Inhibition on Various Natriuretic Peptide Assays) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure09/01/2019
- Mini-Focus Issue: Natriuretic PeptideEffect of Neprilysin Inhibition on Various Natriuretic Peptide Assays08/31/2019
- Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients08/29/2019
- Original articlePlasmatic levels of N-terminal pro-atrial natriuretic peptide in preeclamptic patients and healthy normotensive pregnant womenConcentraciones plasmáticas de fragmento N-terminal del propéptido natriurético auricular plasmático en pacientes con preeclampsia y embarazadas normotensas sanas☆08/28/2019
